COOPERS CEPRAVIN DRY COW INTRAMAMMARY ANTIBIOTIC

Χώρα: Αυστραλία

Γλώσσα: Αγγλικά

Πηγή: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Δραστική ουσία:

CEPHALONIUM DIHYDRATE

Διαθέσιμο από:

INTERVET AUSTRALIA PTY LIMITED

INN (Διεθνής Όνομα):

cephalonium dihydrate(89.9g/kg)

Φαρμακοτεχνική μορφή:

MISC. INTRA MAMMARY

Σύνθεση:

CEPHALONIUM DIHYDRATE ANTIBIOTIC Active 89.9 g/kg

Μονάδες σε πακέτο:

100 Cow Herd Pack; 100 x 3g Syringes; 144 x 3g Syringes; 200 Cow Herd Pack; 50 Cow Herd Pack (1); 50 Cow Herd Pack (2); 80 Cow H

Kατηγορία:

VM - Veterinary Medicine

Κατασκευάζεται από:

INTERVET AUSTRALIA

Θεραπευτική ομάδα:

CATTLE (NOT LACTATING DAIRY) | BOVINE

Θεραπευτική περιοχή:

ANTIBIOTIC & RELATED

Θεραπευτικές ενδείξεις:

CITROBACTER FREUNDII SPP. | CORYNEBACTERIUM PYOGENES | CORYNEBACTERIUM ULCERANS | ENTEROBACTER SPP. | ESCHERICHIA COLI (E. COLI) | KLEBSIELLA SPP. | MASTITIS | PROTEUS SPP. | STAPHYLOCOCCUS AUREUS | STREPTOCOCCUS AGALACTIAE | STREPTOCOCCUS DYSGALACTIAE | STREPTOCOCCUS UBERIS | INCLUDING B-LACTAMASE PRODUCIN | SUBCLINICAL MASTITIS

Περίληψη προϊόντος:

Poison schedule: 4; Withholding period: WHP: Meat: DO NOT USE less than 21 days before slaughter for human consumption . Milk: DO NOT USE in lactating cows or within 49 days of calving. After cal ving colosrum or milk from treated cow s MUST NOT BE USED for human consumptio n or processing for 96 hours (8 milking s).; Host/pest details: CATTLE (NOT LACTATING DAIRY): [CITROBACTER FREUNDII SPP., CORYNEBACTERIUM PYOGENES, CORYNEBACTERIUM ULCERANS, ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), KLEBSIELLA SPP., MASTITIS, PROTEUS SPP., STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS AGALACTIAE, STREPTOCOCCUS DYSGALACTIAE, STREPTOCOCCUS UBERIS]; For sustained, broad spectrum control of and protection against mastitis-causing bacteria (including penicillin resistant strains) in non-lactating dairy cattle. Aids in the reduction of clinical/subclinical mastitis in the subsequent lactation.Do not use in lactating cows. Do not use in cows with a dry period less than 49 days. NOT TO BE USED within 49 days of calving. Use only at the time of drying off.

Καθεστώς αδειοδότησης:

Registered

Ημερομηνία της άδειας:

2023-07-01

Φύλλο οδηγιών χρήσης

, r
COOPERS
CEPRAVIN
DRY
COW
INTRAMAMMARY
ANTIBIOTIC
47940
57968
RLP
V2-
7
Feb
2013
TEMPLATE
FOR
RELEVANT
LABEL
PARTICULARS
(RLPS)
(VETERINARY
PRODUCTS)
Select appropriate:
[J
New
Product (include
all
applicable
RLPs)
OR
liil
Variation
(highlight instructions
that
are
being
varied).
Approval
no.
of
label
being
varied:
[APVMA NO.47940
ATS
NO.
57968]
Signal
heading:
Product
name:
Active
constituenUs:
Statement
of
CLAIMS:
[Shorl Claim]
[Long Claim]
Net
contents:
PRESCRIPTION
ANIMAL
REMEDY
KEEP
OUT
OF
REACH
OF
CHILDREN
FOR
ANIMAL
TREATMENT
ONLY
COOPERS®
CEPRA
VIN®
DRY
COW
LNTRAMAMMARY ANTIBIOTIC
ACTIVE
CONSTITUENT:
CEPHALONIUM DIHYDRATE
89.9
g/kg.
..
HT.P
For sustained, broad spectrum control
of
and protection against mastitis-
causing bacteria (including penicillin-resistant strains)
in
non-lactating dairy
cattle.
Aids
in
the reduction of clinical mastitis and subclinical mastitis
in
the
subsequent lactation.
Each single dose 3g syringe contains 250mg cephalonium dehydrate in a
long-
acting base.
Coopers Cepravin Dry Cow is a long-acting intramammary cerate
containing
cephalonium, a semi-synthetic cephalosporin antibiotic.
It is formulated
to
give
effective antibiotic levels in the non-lactating udder.
Coopers Cepravin Dry Cow is recommended for dry cow therapy to treat
existing
sub-clinical infections and to prevent new infections which occur
during the dry
period.
Cepravin
Dry
Cow aids
in
the
reduction
of
clinical
mastitis
and
subclinical mastitis
in
the subsequent lactation.
Infusion at drying off should
be
part of a mastitis control program
on
the advice of your veterinary surgeon and
will reduce the risk of mastitis that may occur at calving.
Cephalonium
is
a
broad
spectrum
cephalosporin
antibiotic
which
has
bactericidal activity against the majority
of
organisms associated with bovine
mastitis.
The antibacterial activity is not impaired
in
the presence of milk.
Cephalonium is active against:
Staphylococcus aureus,
including penicillin
resistant strains,
Streptococcus aga/actiae, Streptococcus dysga/actiae,
S

Αρχείο Π.Χ.Π.

PRODUCT NAME: COOPERS® CEPRAVIN® DRY COW INTRAMAMMARY
ANTIBIOTIC
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Antibiotic preparation in a long acting base.
TRADE NAME:
COOPERS
® CEPRAVIN
® DRY COW INTRAMAMMARY ANTIBIOTIC
RECOMMENDED USE:
For the treatment of and prophylaxis against mastitis in dry dairy
cows.
APVMA NO:
47940
CREATION DATE:
July, 2009
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S24/25. Avoid contact with skin and eyes.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
A dark blue coloured liquid in single dose syringes.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. This is
an antibiotic preparation.
Any person with a history of allergies to this class of substances
should avoid all contact with this product as it may cause
sensitisation.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term skin exposure.
EYE CONTACT:
SHORT TERM EXPOSURE
: T